Treatment of Argentine hemorrhagic fever

Antiviral Research

Volumn 78, Issue 1, 2008, Pages 132-139

  Enria, Delia A ^a   Briggiler, Ana M ^a   Sánchez, Zaida ^a  

^a Instituto Nacional de Enfermedades Virales Humanas Dr Julio I Maiztegui   (Argentina)

Author keywords

Arenavirus; Argentine hemorrhagic fever; Junin virus; Viral hemorrhagic fever

Indexed keywords

6 FLUORO 3 HYDROXY 2 PYRAZINECARBOXAMIDE; ANTISERUM; ANTIVIRUS AGENT; CONSENSUS INTERFERON; IMMUNOGLOBULIN; JUNIN VIRUS VACCINE; LIVE VACCINE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; NSC 20625; PLACEBO; PYRAZINE DERIVATIVE; RIBAVIRIN; ST 294; T 705; UNCLASSIFIED DRUG; VIRUS VACCINE; XBY 52;

ANEMIA; ARGENTINA; ARGENTINE HEMORRHAGIC FEVER; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE MODEL; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; FATALITY; HEMORRHAGIC FEVER; HUMAN; INFECTION PREVENTION; JUNIN VIRUS; LOADING DRUG DOSE; MORBIDITY; NONHUMAN; PRIORITY JOURNAL; SYMPTOM;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ARENAVIRUSES, NEW WORLD; ARGENTINA; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; DOUBLE-BLIND METHOD; GUINEA PIGS; HEMORRHAGIC FEVER, AMERICAN; HUMANS; IMMUNE SERA; JUNIN VIRUS; MICE; RATS; RIBAVIRIN;

ARENAVIRUS; JUNIN VIRUS; RODENTIA;

EID: 40749147093     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2007.10.010     Document Type: Article

References (52)

1. Avila M.M., Samoilovich S.R., Laguens R.P., Merani M.S., and Weissenbacher M.C. Protection of Junin virus-infected marmosets by passive administration of immune serum: association with late neurological signs. J. Med. Virol. 21 1 (1987) 67-74
2. Bolken T.C., Laquerre S., Zhang Y., Bailey T.R., Pevear D.C., Kickner S.S., Sperzel L.E., Jones K.F., Warren T.K., Amanda Lund S., Kirkwood-Watts D.L., King D.S., Shurtleff A.C., Guttieri M.C., Deng Y., Bleam M., and Hruby D.E. Identification and characterization of potent small molecule inhibitor of hemorrhagic fever New World arenaviruses. Antiviral Res. 69 2 (2006) 86-97
3. Boxaca M.C., Parodi A.S., Rugiero H., and y Blay R. Fiebre Hemorrágica experimental en el cobayo (virus Junin). Rev. Soc. Argent. Biol. 37 (1961) 170
4. de Bracco M.M.E., Rimoldi M.T., Cossio P.M., Rabinovich A., Maiztegui J.I., Carballal G., and Arana R.M. Argentine hemorrhagic fever: alterations of the complement system and anti-Junin virus humoral response. N. Engl. J. Med. 299 (1978) 216-221
5. Bray M. Pathogenesis of viral hemorrhagic fever. Curr. Opin. Immunol. 17 4 (2005) 399-403
6. Buchmeier M.J., de la Torre, et al. Arenaviridae: the virus and their replication. In: Knipe D.M., Howley P.M., Griffinet D.E., et al. (Eds). Fields Virology (2006), Williams and Wilkins, Lippincott
7. Cristiano E., Huerta M., D'Avino P., Enria D., Briggiler A., and Maiztegui J. Potenciales evocados auditivos de tronco cerebral en períodos alejados de la fiebre hemorrágica Argentina. Medicina (B. Aires) 45 (1985) 409
8. Enria D. Arenaviral hemorrhagic fevers: Argentine hemorrhagic fever and Lassa fever. Emerging neurological infections. In: Power C., and Johnson R.T. (Eds). Neurological Disease and Therapy vol. 67 (2005) p. 505
9. Enria D.A., and Barrera Oro J.G. Junin virus vaccines. In: Oldstone M.B.O. (Ed). Arenaviruses. II. The Molecular Pathogenesis of Arenavirus Infections vol. 263 (2002), Springer-Verlag 239-264 Curr. Top. Microbiol. Immunol.
10. Enria D.A., and Maiztegui J.I. Antiviral treatment of Argentine hemorrhagic fever. Antiviral Res. 23 (1994) 23-31
11. Enria D.A., de Damilano A.J., Briggiler A.M., Feuillade M.R., Fernández N.J., and Maiztegui J.I. Modificación de la respuesta humoral específica en enfermos de FHA tratados con plasma inmune. Medicina (B. Aires) 43 6/2 (1983) 869
12. Enria D.A., Briggiler A.M., Fernández N.J., Levis S.C., and Maiztegui J.I. Importance of dose of neutralizing antibodies in treatment of Argentine hemorrhagic fever with immune plasma. Lancet ii 8397 (1984) 255-256
13. Enria D.A., Damilano A.J., Briggiler A.M., Ambrosio A.M., Fernández N.J., Feuillade M.R., and Maiztegui J.I. Sindrome neurológico tardío en enfermos de Fiebre Hemorrágica Argentina tratados con plasma inmune. Medicina (B. Aires) 45 (1985) 615-620
14. Enria D., García Franco S., Ambrosio A., Vallejos D., Levis S., and Maiztegui J. Current status of the treatment of Argentine hemorrhagic fever. Med. Microbiol. Immunol. 175 (1986) 173-176
15. Enria D.A., Briggiler A.M., Levis S., Vallejos D., Maiztegui J.I., and Canonico P.G. Tolerance and antiviral effect of ribavirin in patients with Argentine hemorrhagic fever. Antiviral Res. 7 (1987) 353-359
16. Enria, D., Bowen, M.D., Mills, J.N., Shieh, W.J., Bausch, D., Peters, C.J., 2004. Arenavirus infections. In: Guerrant, R.L., Walker, D. H., Weller, P.F., Saunders, W.B. (Eds.), Tropical Infectious Diseases: Principles, Pathogens, and Practice, vol. 2, pp. 1191-1212 (Chapter 111).
17. Fennewald S.M., Scott E.P., Zhang L., Yang X., Aronson J.F., Gorenstein D.G., Luxon B.A., Shope R.E., Beasley D.W., Barret A.D., and Herzog N.K. Thioaptamer decoy targeting of AP-1 proteins influences cytokine expression and the outcome of arenavirus infections. J. Gen. Virol. 88 3 (2007) 981-990
18. García C.C., Candurra N.A., and Damonte E.B. Antiviral and virucidal activities against arenaviruses of zinc-finger active compounds. Antivir. Chem. Chemother. 11 3 (2000) 231-237
19. Gowen B.B., Barnard D.L., Smee D.F., Wong M.H., Pace A.M., Jung K.H., Winslow S.G., Bailey K.W., Blatt L.M., and Sidwell R.W. Interferon alfacon-1 protects hamsters from lethal Pichinde virus infection. Antimicrob. Agents Chemother. 49 6 (2005) 2378-2386
20. Gowen B.B., Smee D.F., Wong M.H., Pace A.M., Jung K.H., Bailey K.W., Blatt L.M., and Sidwell E.W. Combinatorial ribavirin and interferon alfacon-1 therapy of acute arenaviral disease in hamsters. Antivir. Chem. Chemother. 17 4 (2006) 175-183
21. Gowen B.B., Wong M.H., Jung K.H., Sanders A.B., Mendenhall M., Bailey K.W., Furuta Y., and Sidwell R.W. In vitro and in vivo activity of T-705 against arenavirus and bunyavirus infections. Antimicrob. Agents Chemother. 51 (2007) 3168-3176
22. Green D.E., Mahlandt B.G., and McKee Jr. K.T. Experimental Argentine hemorrhagic fever in rhesus macaques: virus-specific variations in pathology. J. Med. Virol. 22 2 (1987) 113-133
23. Gross P.A.M., Gitlin D., and Janeway C.A. The gamma globulins and their significance (concluded). IV. Therapeutic uses of gamma globulins. N. Engl. J. Med. 260 (1959) 179
24. Heller M.V., Saavedra M.C., Falcoff R., Maiztegui J., and Molinas F. Increased tumor necrosis factor-levels in Argentine hemorrhagic fever. J. Infect. Dis. 166 5 (1992) 1203-1204
25. Heller M.V., Marta R.F., Sturk A., Maiztegui J.I., Hack C.E., ten Cate J.W., and Molinas F.C. Early markers of blood coagulation and fibrinolysis activation in Argentine hemorrhagic fever. Thromb. Haemost. 73 3 (1995) 368-373
26. Huggins J.W., Jahrling P.B., Kende M., and Canonico P.G. Efficacy of ribavirin against virulent RNA virus infections. In: Smith R.A., Knight V., and Smith J.A.D. (Eds). Clinical Applications of Ribavirin (1984), Academic Press, Orlando, FL 49-63
27. Kenyon R.H., Canonico P.G., Green D.E., and Peters C.J. Effect of ribavirin and tributylribavirin on Argentine hemorrhagic fever (Junin virus) in guinea pigs. Antimicrob. Agents Chemother. 29 3 (1986) 521-523
28. Kenyon R.H., Green D.E., Eddy G.A., and Peters C.J. Treatment of Junin virus-infected guinea pigs with immune serum: development of late neurological disease. J. Med. Virol. 20 3 (1986) 207-218
29. Kenyon R.H., Green D.E., Maiztegui J.I., and Peters C.J. Viral strain dependent differences in experimental Argentine hemorrhagic fever (Junin virus) infection of guinea pigs. Intervirology 29 3 (1988) 133-143
30. Kenyon R.H., Condie R.M., Jahrling P.B., and Peters C.J. Protection of guinea pigs against experimental Argentine hemorrhagic fever by purified human IgG: importance of elimination of infected cells. Microb. Pathog. 9 (1990) 219-226
31. Levis S.C., Saavedra M.C., Céccoli C., Falcoff E., Enria D., de Sensi M., Maiztegui J., and Falcoff R. Endogenous interferon in Argentine hemorrhagic fever. J. Infect. Dis. 149 (1984) 428-433
32. Levis S.C., Saavedra M.C., Ceccoli C., Feuillade M.R., Enria D.A., Maiztegui J.I., and Falcoff R. Correlation between endogenous interferon and the clinical evolution of patients with Argentine hemorrhagic fever. J. Interferon Res. 5 (1985) 383-389
33. Maiztegui J.I. Clinical and epidemiological patterns of Argentine hemorrhagic fever. Bull. WHO 52 (1975) 567-575
34. Maiztegui J.I., Fernández N.J., and de Damilano A.J. Efficacy of immune plasma in treatment of Argentine hemorrhagic fever and association between treatment and a late neurological syndrome. Lancet 2 8154 (1979) 1216-1217
35. Marta R.F., Montero V.S., and Molinas F.C. Systemic disorders in Argentine haemorrhagic fever. Bull. Inst. Pasteur 96 (1998) 115-124
36. Marta R.F., Montero V.S., Hack C.E., Sturk A., Maiztegui J.I., and Molinas F.C. Proinflammatory cytokines and elastase-ά-1-antitrypsin in Argentine hemorrhagic fever. Am. J. Trop. Med. Hyg. 60 1 (1999) 85-89
37. Marta R.F., Enria D., and Molinas F.C. Relationship between hematopoietic growth factors levels and hematological parameters in Argentine hemorrhagic fever. Am. J. Hematol. 64 (2000) 1-6
38. McKee K., Mahlandt B.G., Maiztegui J.I., Eddy G.A., and Peters C.J. Experimental Argentine hemorrhagic fever in rhesus macaques: viral strain-dependent clinical response. J. Infect. Dis. 152 1 (1985) 218-221
39. McKee Jr. K.T., Mahlandt B.G., Maiztegui J.I., Green D.E., and Peters C.J. Virus-specific factors in experimental Argentine hemorrhagic fever in rhesus macaques. J. Med. Virol. 22 2 (1987) 99-111
40. McKee Jr. K.T., Huggins J.W., Trahan C.J., and Mahlandt B.G. Ribavirin prophylaxis and therapy for experimental Argentine hemorrhagic fever. Antimicrob. Agents Chemother. 32 9 (1988) 1304-1309
41. Molinas F.C., and Maiztegui J.I. Coagulation studies in Argentine hemorrhagic fever. J. Infect. Dis. 143 (1981) 1-6
42. Montardit A.I., Fernández N.J., De Sensi M.R.F., Damilano A.J., and Maiztegui J.I. Neutralización de la viremia en enfermos de fiebre hemorrágica Argentina tratados con plasma inmune. Medicina (B. Aires) 39 (1979) 799
43. Rinaldo Jr. C.R. Passive immunization against poliomyelitis: the hammon gamma globulin field trials, 1951-1953. Am. J. Public Health 95 5 (2005) 790-800
44. Rodríguez M., McCormick J.B., and Weissenbacher M. Antiviral effect of ribavirin on Junin virus replication in vitro. Rev. Argent. Microbiol. 18 2 (1986) 69-74
45. Ruggiero H.R., Cintora F.A., Magnoni C., et al. Fiebre hemorrágica Argentina. Formas clín. Rev. Assoc. Med. Arg. 78 (1964) 500-510
46. Ruggiero H., Astarloa L., Cintora A., et al. Tratamiento de la Fiebre Hemorrágica Argentina. Uso de plasma de convalecientes y drogas inmunosupresoras. Medicina (B. Aires) 37 3 (1977) 210-215
47. Saavedra M.C., Briggiler A.M., Enria D., Riera L., and Ambrosio A.M. Prevalencia de anticuerpos para el virus de la Hepatitis C en donantes de plasma para el tratamiento de la Fiebre Hemorrágica Argentina. Medicina (B. Aires) 57 (1997) 287-293
48. Shulman N.R. Assessment of hematologic effects of ribavirin in humans. In: Smith R.A., Knight V., and Smith J.A.D. (Eds). Clinical Applications of Ribavirin (1984), Academic Press, Orlando, FL 79-92
49. Vallejos D.A., Ambrosio A.M., Feuillade M.R., and Maiztegui J.I. Lymphocyte subsets alteration in patients with Argentine hemorrhagic fever. J. Med. Virol. 27 (1989) 160-163
50. Weissenbacher M.C., Guerrero L.B., and Parodi A.S. Acción de los inmunosueros en la fiebre hemorrágica experimental. Medicina (B. Aires) 28 (1968) 53-58
51. Weissenbacher M.C., Avila M.M., Calello M.A., Merani M.S., McCormick J.B., and Rodríguez M. Effect of ribavirin and immune serum on Junin virus-infected primates. Med. Microbiol. Immunol. 175 (1986) 183-186
52. Weissenbacher M.C., Calello M.A., Merani M.S., McCormick J.B., and Rodriguez M. Therapeutic effect of the antiviral agent ribavirin in Junin virus infection of primates. J. Med. Virol. 20 3 (1986) 261-267